Sosei Group Corporation appointed Mr. Chris Cargill as Executive Vice President and Chief Financial Officer with immediate effect. Mr. Cargill was appointed Interim CFO in June 2018 having previously been a Senior Vice President in the Company. Prior to joining Sosei, Mr. Cargill spent nearly a decade in Investment Banking at J.P. Morgan and held various positions of increasing responsibility, most recently as Vice President in the U.K. Corporate Finance Group, focused on the Healthcare sector.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,393 JPY | -2.86% | -1.28% | -1.97% |
04-18 | Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May | MT |
04-17 | Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.97% | 821M | |
-2.95% | 90.75B | |
-1.97% | 39.03B | |
-15.47% | 31.85B | |
+61.15% | 26.26B | |
-22.81% | 14.13B | |
-8.82% | 12.87B | |
-11.77% | 11.6B | |
-45.97% | 10.91B | |
+3.15% | 8.89B |
- Stock Market
- Equities
- 4565 Stock
- News Nxera Pharma Co., Ltd.
- Sosei Group Corporation Appoints Chris Cargill as Executive Vice President and Chief Financial Officer